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Atrial fibrillation (AF) is he most commonly encountered arrhythmia in clinical practice, with
an overall prevalence of 0.4% in the general population. Recent advances in technology and
in the understanding of the pathophysiology of AF have led to more definitive and potentially
curative therapeutic approaches. Echocardiography has a well-established role in the
assessment of cardiac structure and function and risk stratification, and has become an
essential part of the guidelines for management of AF. The development of intracardiac
echocardiography has led to real-time guidance of percutaneous interventions, including
radiofrequency ablation and left atrial appendage closure procedures for patients with AF.
Other imaging modalities, including computed tomography and magnetic resonance angiog-
raphy, have allowed for more accurate measurement and better understanding of the cardiac
anatomy. We review the impact of various imaging modalities in the evaluation and
management of AF. (J Am Coll Cardiol 2006;48:2077–84) © 2006 by the American
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.06.072College of Cardiology Foundation
b
p
n
u
p
c
t
p
T
N
r
b
a
o
r
a
p
(
e
v
n
t
s
c
s
l
otrial fibrillation (AF) is the most commonly encountered
rrhythmia in clinical practice, with an overall prevalence of
.4% in the general population (1). Recent advances in
echnology and in the understanding of the pathophysiology
f AF have led to more definitive and potentially curative
herapeutic approaches. Echocardiography has a well-
stablished role in the assessment of cardiac structure and
unction, risk stratification, and has become an essential part
f the guidelines for management of AF (2). The develop-
ent of intracardiac echocardiography has led to real-time
uidance of percutaneous interventions, including radiofre-
uency ablation and left atrial appendage closure procedures
or patients with AF. Other imaging modalities, including
omputed tomography (CT) and magnetic resonance an-
iography (MRA), have allowed for more accurate measure-
ent and better understanding of the cardiac anatomy. In
his work, we review the impact of various imaging modal-
ties in the evaluation and management of AF.
OLE OF ECHOCARDIOGRAPHY IN AF
ransthoracic echocardiography. Transthoracic echocar-
iography (Tables 1 and 2) identifies conditions that pre-
ispose patients to AF. This information can influence the
ubsequent management strategies; a structurally normal
eart may suggest a triggered mechanism for AF that may
From the *Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland,
hio; †Taipei Veterans General Hospital and ‡I-Lan Hospital, Taipei, Taiwan; and
The Division of Cardiology and Cardiovascular Research Center, National Yang-
ing University, School of Medicine, Taipei, Taiwan.w
Manuscript received March 1, 2006; revised manuscript received May 31, 2006,
ccepted June 6, 2006.e amenable to radiofrequency (RF) ablation whereas the
resence of severe mitral stenosis makes long-term mainte-
ance of normal sinus rhythm (NSR) unlikely. Left ventric-
lar (LV) systolic function helps to guide the choice of
harmacologic therapy for rate and rhythm control in
hronic AF.
The size of the left atrium (LA) can be readily assessed by
ransthoracic echocardiography. Sustained AF can lead to
rogressive increase in LA size, termed atrial remodeling.
his remodeling may be reversed with the restoration of
SR. Diameter measurements of the LA may not be
eflective of the true extent of LA enlargement as measured
y LA volume (3,4). Increased LA volume is associated with
low probability of successful cardioversion for chronic AF
r maintenance of NSR (5–7).
Disordered atrial contractions in AF result in a 20% to 30%
eduction in stroke volume and cardiac output, which is further
ccentuated in those patients with heart disease. The ratio of
eak early transmitral velocity (E) to early diastolic annular
Ea) velocity (the E/Ea ratio) has been shown to reliably
stimate LV filling pressures in patients with AF (8). Cardio-
ersion may lead to improved LV filling because of synchro-
ized atrial activity and function. Van Gelder et al. (9) found
hat improvement in ejection fraction and peak oxygen con-
umption lag behind improvement in atrial function after
ardioversion. The improved ventricular function after conver-
ion to NSR leads ultimately to improved exercise tolerance,
ess fatigue, resolution of dyspnea and chest discomfort, and
verall decreased morbidity (9,10).
Atrial mechanical function is difficult to assess in patients
ith AF. Upon conversion to NSR, one can reassess the
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ary venous atrial reversal using pulsed-wave Doppler, as
ell as the mitral late diastolic annular velocity from tissue
oppler imaging. During AF, early transmitral velocities
re abnormal and reduced. Atrial stunning has been docu-
ented with spontaneous and pharmacological cardiover-
ion (11). Depending on the duration of AF and degree of
trial stunning, the peak transmitral atrial wave velocity may
emain reduced for up to 4 weeks after successful cardio-
ersion, which is the basis for the anticoagulation guidelines
fter conversion (12).
In our experience, atrial volume diminishes and mechan-
cal function improves or is unchanged after isolation of the
ulmonary vein (PV). On the other hand, procedures
argeting the anterior and anterolateral aspects of the LA
ay result in decreased LA function (13). Recently, LV
unction has been shown to improve with PV isolation in
atients with AF and heart failure (14,15).
ransesophageal echocardiography. Transesophageal
chocardiography (TEE) is the modality of choice for
etecting LA or left atrial appendage (LAA) thrombi with
sensitivity and specificity of approximately 95% to 100%
11) (Fig. 1). In patients with pre-existing thrombus, TEE
hould be used to confirm thrombus resolution before
ttempts at cardioversion. Varying degrees of blood stasis
ave been described, ranging from spontaneous echo con-
rast (SEC) to “sludge.” Spontaneous echo contrast, iden-
ified as swirling echodensity, reflects increased erythrocyte
ggregation, the presence of fibrinogen, and a low flow state
nd is associated with later development of thrombus and
ith systemic embolization (8,11). Sludge is a viscid
able 1. Echocardiography in Atrial Fibrillation
TTE
eneral anatomy of cardiac structures More detailed assessmen
function
ssessment of LV function, valve function Assessment of pulmona
velocity
ssessment of chamber size Detection of thrombotic
Abbreviations and Acronyms
AF  atrial fibrillation
CT  computed tomography
ICE  intracardiac echocardiography
LA  left atrium
LAA  left atrial appendage
LV  left ventricular
MDCT  multidetector computed tomography
MRA  magnetic resonance angiography
NSR  normal sinus rhythm
PV  pulmonary vein
RF  radiofrequency
SEC  spontaneous echo contrast
TEE  transesophageal echocardiographyCE  intracardiac echocardiography; LAA  left atrial appendage; LV  left ventricular;chodensity in the LA or LAA without clear thrombus
ormation. Sludge represents thrombus in situ that is a stage
arther along the continuum toward thrombus formation. A
egative correlation between peak LAA emptying velocity
nd SEC highlights the relation of LAA dysfunction to
hrombus formation (16–18). It is important to note that
nticoagulation does not influence the presence of SEC
ecause it does not change the underlying hemodynamic
bnormalities.
The finding of thrombus on TEE portends a very poor
utcome. In one observational study, it was associated with
n embolic risk of up to 10.4% per year and a death risk of
5.8% in a series of patients, most of whom were receiving
ral anticoagulation (19). Despite the sensitivity of multi-
lane TEE being 95%, thrombi 2 mm may still be
issed, given the complex morphology of multilobed LAA.
he percentage of thrombus resolution after 4 to 6 weeks of
nticoagulation has varied widely from 5% to 90% (20–23).
t is generally accepted that 20% of thrombus may still be
resent.
The mechanical function of LAA is best assessed using
EE. Low LAA emptying velocities (20 cm/s) correlate
trongly with the presence of SEC and thrombus formation
24,25), whereas LAA emptying velocities 40 cm/s pre-
ict greater likelihood of sustained NSR 1 year after
ardioversion (19). In AF without thrombus, LAA appears
o passively empty and fill with multiple small fibrillatory
ontractions that do not contribute to LV filling. There is
ecreased or no demonstrable flow observed in those with
hrombus. In contrast, LAA function during NSR has the
ormal characteristic pattern of emptying, resulting in a
ell-defined, pulsed-wave Doppler signal (26,27).
ransesophagealechocardiography-guidedcardioversion.
he ACUTE (Assessment of Cardioversion Using
ransesophageal Echocardiography) trial (28) compared
TEE-guided strategy combined with short-term anti-
oagulation using a conventional 3-week oral anticoagu-
ation precardioversion strategy. Although there was a
ignificant difference in the composite end point of major
nd minor bleeding and a shorter time to cardioversion,
here was no difference in the composite end point of
troke, transient ischemic attack, and peripheral embo-
ism. The ACUTE II pilot trial compared TEE-guided
ardioversion using low molecular weight heparin with
ntravenous unfractionated heparin in 155 patients and
ICE
alve structure and Interventional anatomic assessment
n flows, LAA emptying Guidance during left atrial ablation
atrial milieu Avoidance and detection of complicationsTEE
t of v
ry vei
leftTEE  transesophageal echocardiography; TTE  transthoracic echocardiography.
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November 21, 2006:2077–84 Cardiovascular Imaging in Atrial Fibrillationhowed similar safety and efficacy with a lower length of
tay and more sinus rhythm in the low molecular weight
eparin group (29). Kinnaird et al. (30) also used TEE to
valuate the PVs before and after RF ablation.
ntracardiac echocardiography. Intracardiac echocardiog-
aphy (ICE) is an essential tool for safe trans-septal access,
dentification of anatomical structures relevant to the abla-
ion, placement, navigation of the circular mapping cathe-
er, titrating energy delivery during ablation, and the early
iagnosis of complications (31,32).
Traditional fluoroscopic landmarks occasionally might be
isleading when there is distortion of the atrial or septal
natomy in conditions such as LA dilation, interatrial septal
neurysm, and previous cardiac surgery, thereby increasing
he risk of complications. The use of ICE allows a safer
pproach for trans-septal puncture and facilitates earlier
dministration of heparin to prevent clot formation on the
rans-septal sheath that can be visualized by ICE. Com-
ared with pulmonary venography, ICE has shown greater
ccuracy to define the antrum. Correct identification of the
natomy is important to allow for the appropriately sized
atheter selection and proper vein treatment due to signif-
cant variation, including a common vestibule of the left
Vs and additional small branches (33,34).
Intracardiac echocardiography can be used to evaluate
atheter movement during lesion delivery without the need
or intermittent fluoroscopy and is helpful in monitoring the
atheter-tissue interface during energy delivery (35). Con-
entionally, temperature, power, and impedance are moni-
ored and RF energy discontinued if they are greater than
he safety thresholds. Using ICE, we have learned that RF
elivery generates microbubbles. By guiding our ablation
itrating power output to limit microbubble formation, we
able 2. Echocardiographic Predictors of Stroke in Patients With
TTE TEE
epressed LV function Increased left atrial size, depressed LV fun
ncreased left atrial size Left atrial thrombus/sludge/spontaneous ec
itral valve stenosis Low LAA emptying velocities
CE  intracardiac echocardiography; LAA  left atrial appendage; LV  left ventrigure 1. Transesophageal echocardiography images of a laminated left atrial app
hrombus (right). Note the presence of severe spontaneous echo contrast.ave seen improved success rates and reduced risk of
omplications, including thromboembolic episodes (36).
he use of ICE guidance in such a way may also prevent
trioesophageal fistulas.
The esophagus has a variable relationship to the PVs and
osterior LA wall. Visualization of this thin-walled struc-
ure can be enhanced by the ingestion of a carbonated
everage. Identification of the esophageal relationship can
revent occurrence of atrioesophageal fistulas by either
ontrolling or avoiding energy delivery during ablation in
his region (37).
Postablation PV narrowing can be quantified with diam-
ter measurement and Doppler flow measurements to assess
or flow turbulence. An increase in flow after ablation is
ikely a marker of extensive swelling, which could theoret-
cally lead to chronic PV stenosis. However, Saad et al. (38)
tudied PV flow before and after PV ostial isolation and
howed that although there were acute changes in the
ostablation diastolic flows, they do not appear to be strong
redictors for chronic PV stenosis. Intracardiac echocardi-
graphy can also be used for intracardiac Doppler assess-
ent of LA contraction and for prediction of success after
V isolation (39,40).
agnetic resonance angiography and multidetector
T. Evolving techniques in catheter ablation of AF have
ed to the expansion of the knowledge of LA anatomy
41–44). Understanding the morphological characteristics
f LA in detail can achieve a more efficient and successful
blation and prevent potential complications. Noninvasive
maging modalities, including MRA and multidetector
omputed tomography (MDCT), can depict the PVs and
A and provide a valuable road map before the catheter
blation of AF (45–51). The advantages of cardiac CT/
ial Fibrillation
ICE
mitral valve stenosis Left atrial spontaneous echo contrast
ntrast Microbubble formation during ablation
Char and thrombus formation visualized on
sheaths/catheters
TEE  transesophageal echocardiography; TTE  transthoracic echocardiography.Atr
ction,
ho coendage (LAA) thrombus (left) and mobile protruding left atrial appendage
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Cardiovascular Imaging in Atrial Fibrillation November 21, 2006:2077–84RA are: 1) imaging the anatomic characteristics of the PV
nd LA preprocedurally; 2) assessing the anatomic relation-
hip of the LA, esophagus, and adjacent vascular structures;
) understanding the morphological remodeling of PV and
A in AF; and 4) detecting postprocedural complications.
xamples of variations in LA anatomy are depicted in
igures 2 and 3. Figure 2 shows an unusual variant of the
A with a roof pouch, and Figure 3 demonstrates a case of
n unusually low LAA. Avoidance of both structures during
blation may be critical in preventing complications.
Figure 2. Left atrial roof pouch in the mFigure 3. Low left atrial appendanatomy of the PVs. The interventional therapy of AF
as been focused on the interruption of electric conduction
y isolating the AF initiators of PVs from LA tissues. The
etailed information of PV anatomy and the relationship
etween PV and LA is mandatory for the mapping and
blation procedures.
The PV ostia are ellipsoid with a longer superior-inferior
imension, and the funnel-shaped ostia are frequently noted
n patients in AF (46). The right superior PV is close to the
uperior vena cava or right atrium, and the right inferior PV
perior posterior wall of the left atrium.ge (LAA), posterior view.
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November 21, 2006:2077–84 Cardiovascular Imaging in Atrial Fibrillationrojects horizontally. The left superior PV is in close vicinity
o the LAA, and the left inferior PV courses near the
escending aorta. These observations are essential for the
rans-septal procedure, placement of a circular mapping
atheter, and the application of energy around or outside the
V ostia.
orphology patterns of PV trees. Although the mor-
hologies of PVs have a certain basic pattern, they are
ore variable than arteries. Variations of PVs can be
eadily demonstrated by cardiac CT/MRA (Table 3).
he variability can substantially influence the success rate
f catheter ablation if the variant veins are inadequately
reated. Several studies reported the existence of supernumer-
ry right PVs, with the incidence ranging from 18% to 29%
45,48,51–54) (Fig. 4A). Tsao et al. (47) used MRA to
emonstrate the PV variant of a discrete right middle PV with
n independent orifice rather than the typical 2 PV ostia in the
ight side. The ectopic focus originating from the right middle
V could initiate AF, which is cured by catheter ablation of
ight middle PV. In addition, a significantly longer distance
etween the PV ostium and first branch was demonstrated for
eft versus right PVs (44). Perez-Lugones el al. (54) showed
hat multiple ramifications and early branching of the right
nferior PV were observed in the study, which might explain
he low incidence of firing of the right inferior PV.
A common trunk of left or right PVs also was imaged
sing CT/MRA. A common ostium is found more
requently on the left-sided PVs (6% to 35%) and results
n a broad PV-atrial junction (Fig. 4B). The common left
V is a consistent origin of arrhythmogenic ectopy (55).
ocalization of the true PV atrial junction in these
atients can be more accurately determined with the
ssistance of the 3-dimensional images before mapping
nd ablation procedures.
able 3. Anatomic Variations of Pulmonary Veins (PVs)
upernumerary PVs
Right 18%–29%
Left 3%
ommon ostium of
Right PVs 1%
Left PVs 3%–35%
arly branching of right inferior PV 66%–99%
Right top” PV 3%igure 4. (A) Supernumerary right pulmonary veins (PVs) (arrows). (B) Broad
uperior pulmonary vein.natomic relationship between LA and adjacent structures.
trioesophageal fistulas have been reported during intraop-
rative RF ablation of AF using the endocardial approach,
ercutaneous PV isolation, and LA ablation (56–59). An
trioesophageal fistula can cause an air embolism with a
troke, mediastinitis, or gastrointestinal bleeding and is
ssociated with a high rate of mortality. Understanding the
natomic relationship of the esophagus and PV/LA pro-
ides useful information for avoiding esophageal injury
uring the catheter ablation. Several studies have demon-
trated the close relationship of the posterior LA, coronary
inus, PVs, and esophagus by CT scan (Figs. 5A to 5C)
60–63). Although the peristalsis and dynamic movement
f the esophagus was suspected to influence the results, the
natomic parameters of the relationship of the esophagus,
Vs, and LA posterior wall are useful in determining the
ocation of the ablation lesions in the LA and to understand
he possible risk of esophageal injury.
The close proximity of the LA roof and right pulmo-
ary artery was also revealed by CT imaging (Fig. 6A).
lthough there were no reported cases of injury to the
ight pulmonary artery, it may be that another structure
ould be damaged when more powerful energy sources
re introduced to make a deep lesion in the LA roof. It is
ikely that the cooling effect of the rapid blood flow may
rotect the right pulmonary artery from heat injury.
owever, to avoid the potential hazard of right pulmo-
ary artery injury, the ablation at the LA roof (especially
ear the right superior PV orifice where the distance to
he right pulmonary artery was the shortest compared to
he other parts of the roof) should be performed with
are.
In addition, the very close vicinity between the LAA
rifice and proximal left circumflex artery was demonstrated
y CT images (Fig. 6B). Takahashi et al. (63) reported a
ase wherein the left circumflex coronary artery was acutely
ccluded during ablation within the coronary sinus. Due to
nergy applications around the LAA that have been recently
roposed to increase the success rate in treating persistent
F, ablation near the anterior base of the LAA orifice must
e conducted with caution to avoid any risk of injury to the
eft circumflex artery.PV-atrial junction. LIPV  left inferior pulmonary vein; LSPV  left
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close to the left atrial appendage (LAA) (B). LS  left superior pulmonary
vein; roof  left atrial roof; RS  right superior pulmonary vein.
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Cardiovascular Imaging in Atrial Fibrillation November 21, 2006:2077–84orphological remodeling of PVs and LA in patients
ith AF. The ostial geometries of PVs have been compre-
ensively evaluated by the use of CT and MRA. Tsao et al.
64,65) first reported the different sizes of PVs among
ontrolled AF, paroxysmal AF, and chronic AF patients by
RA images. Furthermore, the significant dilatation of
oth superior PVs with simultaneous LA enlargement was
emonstrated among patients with paroxysmal AF and
hronic AF. After successful ablation of arrhythmogenic
V, the dilated (nonablated) PVs could regress during
ong-term follow-up (65). Several reports demonstrated the
orphological remodeling and reverse remodeling process
f LA and PVs in patients in AF (66–68).
etection of complications after catheter ablation. The
easibility and safety of catheter ablation of the PVs and LA
ave been well documented. However, the procedure-related
ajor complications, including cerebral emboli, PV stenosis,
nd pericardial effusion with tamponade, could occasionally be
ncountered. The use of MRA and CT can detect PV stenosis
fter ablation of AF (69–72). Acquired PV stenosis after PV
blation was a major concern when RF energy was applied
round or inside the PV ostia. Although a single PV stenosis
an be asymptomatic, the severity of clinical symptoms may be
elated to the numbers and stenotic degree of the involved
eins. The use of MDCT and MRA can effectively delineate
he lesions and provide the information for justification of
reatment (70–72). The ROTEA (Role of TEE in Pulmonary
ein Ablation: Comparison with Computed Tomography)
tudy is an ongoing prospective study assessing the incidence of
V stenosis detected by TEE compared with MDCT.
onclusions. Echocardiography continues to be the foun-
ation of clinical management of AF. TEE continues to be
he gold standard to exclude LAA thrombus pre-
rocedurally; however, MDCT is increasingly being used to
xclude thrombus and shows excellent negative predictive
alue (73). However, successful catheter ablation of AF
ighly depends on understanding the LA and PV anatomy.
m (LA) to adjacent structures. Note proximity of esophagus to left inferior
I) in B. (C) The esophagus (Eso) abuts the coronary sinus (CS). Ao igure 5. Computed tomography scan depicting the relationship of the left atriu
ulmonary vein in A and to the antrum of the right inferior pulmonary vein (Rigure 6. Computed tomography scan depicting the relationship of the left
trium to adjacent structures. Note the course of the pulmonary artery (PA)
long the roof of the left atrium (A) and of the left circumflex artery (LCX)dvances in imaging technology have improved the quality
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lectrophysiologists to perform ablations within the LA.
amiliarity with the normal and variant patterns of PVs, the
mportant landmarks within the LA, and the topographic
elationship of the LA and the surrounding structures is
mportant before the ablation procedure.
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